HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 80 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $281,000 | -32.5% | 31,758 | -3.6% | 0.00% | 0.0% |
Q2 2022 | $416,000 | +37.7% | 32,949 | +106.6% | 0.00% | 0.0% |
Q1 2022 | $302,000 | -42.6% | 15,949 | +6.4% | 0.00% | 0.0% |
Q4 2021 | $526,000 | -2.2% | 14,988 | +2.0% | 0.00% | 0.0% |
Q3 2021 | $538,000 | +1.5% | 14,688 | +8.9% | 0.00% | 0.0% |
Q2 2021 | $530,000 | +55.4% | 13,488 | +11.6% | 0.00% | 0.0% |
Q1 2021 | $341,000 | -8.1% | 12,088 | +4.4% | 0.00% | 0.0% |
Q4 2020 | $371,000 | -10.4% | 11,574 | -9.6% | 0.00% | 0.0% |
Q3 2020 | $414,000 | -35.0% | 12,810 | -44.5% | 0.00% | -50.0% |
Q2 2020 | $637,000 | +37.3% | 23,084 | -11.2% | 0.00% | +100.0% |
Q1 2020 | $464,000 | +45.0% | 25,984 | +103.7% | 0.00% | 0.0% |
Q4 2019 | $320,000 | -43.0% | 12,758 | -59.4% | 0.00% | 0.0% |
Q3 2019 | $561,000 | -50.6% | 31,458 | -39.1% | 0.00% | -66.7% |
Q2 2019 | $1,136,000 | -18.6% | 51,639 | +13.1% | 0.00% | -25.0% |
Q1 2019 | $1,396,000 | -34.9% | 45,639 | -50.9% | 0.00% | -33.3% |
Q4 2018 | $2,145,000 | – | 92,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERAL ATLANTIC, L.P. | 4,000,000 | $67,760,000 | 1.05% |
M&G INVESTMENT MANAGEMENT LTD | 7,084,834 | $120,442,178 | 0.54% |
Bellevue Group AG | 1,802,963 | $30,584,761 | 0.49% |
AIA Group Ltd | 391,278 | $6,628,249 | 0.32% |
PLATINUM INVESTMENT MANAGEMENT LTD | 182,052 | $3,083,961 | 0.12% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 4,219,168 | $71,472,706 | 0.11% |
Hennion & Walsh Asset Management, Inc. | 51,735 | $876,391 | 0.06% |
Allianz Asset Management GmbH | 1,644,999 | $27,866,283 | 0.05% |
Janney Capital Management LLC | 17,203 | $291 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 193,811 | $3,268 | 0.01% |